|
|
|
Volumn 95, Issue 11, 2004, Pages 286-290
|
|
HB-EGF is a promising target molecule for ovarian cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BACTERIAL PROTEIN;
CRM197 (NON TOXIC VARIANT OF DIPHTHERIA TOXIN);
CRM197 (NON-TOXIC VARIANT OF DIPHTHERIA TOXIN);
EPIDERMAL GROWTH FACTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR;
HEPARIN BINDING EPIDERMAL GROWTH FACTOR;
HEPARIN-BINDING EGF-LIKE GROWTH FACTOR;
LIGAND;
LYSOPHOSPHATIDIC ACID;
LYSOPHOSPHOLIPID;
ANIMAL;
CELL DIVISION;
DRUG ANTAGONISM;
DRUG DESIGN;
DRUG EFFECT;
FEMALE;
GENETICS;
HUMAN;
OVARY TUMOR;
PATHOLOGY;
PHYSIOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BACTERIAL PROTEINS;
CELL DIVISION;
DRUG DESIGN;
EPIDERMAL GROWTH FACTOR;
FEMALE;
HUMANS;
LIGANDS;
LYSOPHOSPHOLIPIDS;
OVARIAN NEOPLASMS;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
SIGNAL TRANSDUCTION;
|
|
EID: 14944347664
PISSN: 0016254X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (12)
|
